Feed AZN.ST
AZ

AstraZeneca PLC

AZN.ST · STO

1,592.50 kr +0.57% (+9.00 kr)
1M +1.09%
Market Cap $245.6B
P/E Ratio 23.53x
Div. Yield 0.64%
ROE 21.68%

Bulios Fair Price

1,974 kr

23.9% upside

Current Price

1,593 kr

Undervalued Fair Value Overvalued

According to Bulios Fair Price, AZN.ST is currently undervalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Strong
8/9
Valuation
54 /100
Fair
P/E 23.53x
PEG 0.53x
EV/EBITDA 13.35x
Growth
74 /100
Growing
EPS growth 45.80%
Book val. growth 9.53%
Rev. growth 9.82%
Profitability
94 /100
Strong
Gross margin 81.83%
FCF margin 15.46%
Net margin 17.02%
Quality
76 /100
Excellent
ROIC 12.71%
Asset turnover 0.52x
ROE 21.68%
Debt
69 /100
Low
Debt/Equity 0.64x
Net debt/EBITDA 1.35x
Current ratio 0.89x
Stability
64 /100
Moderate
Beta 0.21x
Profitable years 6
Rev. volatility 7.46%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about AZN.ST
Online

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Pascal Claude Roland Soriot

Employees

96,100

Headquarters

Cambridge

Upcoming events

30 OCT

Earnings

Upcoming earnings report

23d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.